This site is hosted by the National Cancer Institute, National Institutes of Health in Bethesda, MD, USA.
Last Update: January 2, 2008
Contact Information
Disclaimers
MIDDLE EAST CANCER CONSORTIUM:
Review ConsiderationsGrant applications will be reviewed via a two-tiered process: the first will involve a review system where experts (peers) in the same fields of research as proposed in the application will evaluate the scientific merit of these applications; the second tier will be consideration of those recommendations by the Board of Governors for approval and funding. The two tiers are described further below.
- TIER 1: Peer Review will be the responsibility of the Division of Extramural Affairs (DEA) of the U.S. National Cancer Institute, in accordance with established procedures for mail review. The peer review will assess: the significance and feasibility of the proposed project, its quality, the importance to cancer research and the goals of the MECC program, the ability and experience of the principal investigator(s) to undertake the proposed project, and the adequacy and appropriateness of the proposed budget.
Please be aware that the application should not include a tutorial on the area to be investigated. Instead, the application should be written at the same scientific and technical levels as in a scientific presentation to peers within the proposed area of research. The application must make clear the relevance to the goals of the MECC program.
- TIER 2: The Board of Governors will review the recommendations of the peer review process for each grant cycle and establish the actual awards based upon the peer review recommendations, policy priorities of the Board, distribution of awards among all the MECC participant countries, and the financial resources made available to this call of proposals by the Board.
All applicants will be notified by the MECC. A written summary statement of the conclusions of the peer review will be provided to each applicant.